ES8608861A1 - Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales de fosfomicina. - Google Patents

Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales de fosfomicina.

Info

Publication number
ES8608861A1
ES8608861A1 ES547624A ES547624A ES8608861A1 ES 8608861 A1 ES8608861 A1 ES 8608861A1 ES 547624 A ES547624 A ES 547624A ES 547624 A ES547624 A ES 547624A ES 8608861 A1 ES8608861 A1 ES 8608861A1
Authority
ES
Spain
Prior art keywords
aminoacids
cis
pharmaceutical compositions
compositions containing
containing salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547624A
Other languages
English (en)
Other versions
ES547624A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering SpA
Original Assignee
Schering SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering SpA filed Critical Schering SpA
Publication of ES8608861A1 publication Critical patent/ES8608861A1/es
Publication of ES547624A0 publication Critical patent/ES547624A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
    • C07F9/65505—Phosphonic acids containing oxirane groups; esters thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE COMPOSICIONES FARMACEUTICAS HIDROSOLUBLES A BASE DE SALES DE FOSFOMICINA. COMPRENDE HACER REACCIONAR: A) SALES DE ACIDO CIS-1,2-EPOXIPROPILFOSFONICO CON AMINOACIDOS CON B) AMINOALCOHOLES, EN UNA RELACION MOLAR QUE OSCILA ENTRE 0,4 Y 0,8, EN SOLUCION ACUOSA O HIDROALCOHOLICA; DONDE EL AMINOALCOHOL ESTA SELECCIONADO ENTRE EL GRUPO FORMADO POR 1,1-DIMETIL-2-AMINOETANOL, 2-AMINOBUTANOL Y 2-AMINO-2-HIDROXIMETIL-1,3-PROPANODIOL; DONDE LA SAL EMPLEADA ES LA SAL DE ARGININA DEL ACIDO CIS-1,2-EPOXIPROPILFOSFONICO (FORFOMICINA); Y DONDE LA RELACION MOLAR DE SAL DE FOSFOMICINA A AMINOALCOHOL ES DE 0,6. TIENEN APLICACIONES FARMACEUTICAS POR SU ACTIVIDAD ANTIBIOTICA, PUDIENDO SER ADMINISTRADAS POR VIA PARENTERAL U OTRAS FORMAS DE SOLUCION.
ES547624A 1984-10-05 1985-10-04 Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales de fosfomicina. Expired ES8608861A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4791/84A CH660305A5 (de) 1984-10-05 1984-10-05 Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.

Publications (2)

Publication Number Publication Date
ES8608861A1 true ES8608861A1 (es) 1986-09-01
ES547624A0 ES547624A0 (es) 1986-09-01

Family

ID=4282601

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547624A Expired ES8608861A1 (es) 1984-10-05 1985-10-04 Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales de fosfomicina.

Country Status (12)

Country Link
US (1) US4783449A (es)
JP (1) JPS62223122A (es)
KR (1) KR860003011A (es)
AT (1) AT383735B (es)
BE (1) BE903368A (es)
CH (1) CH660305A5 (es)
DE (1) DE3535355A1 (es)
ES (1) ES8608861A1 (es)
FR (1) FR2572934B1 (es)
GB (1) GB2165153B (es)
IT (1) IT1201478B (es)
NL (1) NL8502713A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003054A1 (de) * 1990-02-02 1991-08-08 Hoechst Ag Verwendung von benzylphosphonsaeurederivaten zur behandlung von durch viren verursachte krankheiten
ITMI20021725A1 (it) * 2002-08-01 2002-10-31 Zambon Spa Composizioni farmaceutiche ad attivita' antibiotica.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH310498A (de) * 1951-11-14 1955-10-31 Waldhof Zellstoff Fab Verfahren zur Stabilisierung von Alkalisalzen von Adenosinpolyphosphorsäuren.
DE1492204A1 (de) * 1962-04-14 1969-07-17 Uhlenbroock Dr Med Kurt Verfahren zur Herstellung von stabilen,waessrigen Injektionsloesungen von Monophenyl-4-butylpyrazolidin-Verbindungen
DE1767212B1 (de) * 1967-04-13 1971-05-06 Sumitomo Chemical Co Verfahren zur Herstellung injizierbarer Arzneimittel
BE756953A (fr) * 1969-10-02 1971-04-01 Merck & Co Inc Potentialisation d'antibiotiques
IT1161974B (it) * 1978-02-02 1987-03-18 Italchemi Spa Derivti dell acido cis.i 2 epossipropilfosfonico loro procedimento di preparazione e composizioni farmaceutiche che li contengono
IT1112282B (it) * 1978-07-19 1986-01-13 Zambon Spa Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato
IT1097578B (it) * 1978-07-31 1985-08-31 Italchemi Spa Metodo per la preparazione di sali dell'acido (-)
IT1124610B (it) * 1979-10-18 1986-05-07 Zambo Spa Mono(2-ammonio-2-idrossimetil-1,3-propandiolo) (2r-cis)-(o-metilossiranil)fosfonato
AU565425B2 (en) * 1982-11-01 1987-09-17 Stichting Katholieke Universiteit Sparsomycin (sc-rs) derivative

Also Published As

Publication number Publication date
FR2572934B1 (fr) 1988-10-28
GB2165153B (en) 1988-03-23
US4783449A (en) 1988-11-08
NL8502713A (nl) 1986-05-01
IT1201478B (it) 1989-02-02
BE903368A (nl) 1986-02-03
DE3535355A1 (de) 1986-04-17
GB8524551D0 (en) 1985-11-06
CH660305A5 (de) 1987-04-15
JPS62223122A (ja) 1987-10-01
KR860003011A (ko) 1986-05-19
ATA286985A (de) 1987-01-15
GB2165153A (en) 1986-04-09
IT8522366A0 (it) 1985-10-04
AT383735B (de) 1987-08-10
FR2572934A1 (fr) 1986-05-16
ES547624A0 (es) 1986-09-01

Similar Documents

Publication Publication Date Title
ES8900017A1 (es) Procedimiento para la preparacion de dipeptidos de n,n-dialquil-guanidino.
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
MY101791A (en) New benzimidazole derivatives
DE3766200D1 (de) L-dopa enthaltendes arzneimittel.
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
ES8802420A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
JPS539394A (en) Preparation of l-lysine by fermentation
ES8608861A1 (es) Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales de fosfomicina.
MY101821A (en) Quinazolinediones and pyridopyrimidinediones
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
JPS52143288A (en) Microbial production of l-amino acids
ES8609351A1 (es) Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales del acido (-) cis-1, 2-epoxi-propilfosfonico.
JPS52111576A (en) Synthesis of 5,7,8-trimethyl-3,4-dehydrotocotrienol
JPS5332193A (en) Preparation of l-glutamic acid by fermentation
FI864146A0 (fi) Mitogena peptider.
JPS52134093A (en) Preparation of l-amino acid by fermentation
SU1769405A1 (ru) Регулятор роста растений
JPS5437882A (en) Stabilization and activation of urokinase
JPS5341492A (en) Preparation of l-glutamic acid by fermentation
ES8606248A1 (es) Un procedimiento para la produccion de una dihidroxifenil- glicina opticamente activa
AU572374B2 (en) Azolyl-aroxymethyl-dimethylpentinols, their use as fungicides
JPS5386088A (en) Preparation of amino acid by fermentation
JPS51125053A (en) Process for preparing n2-(5, 6, 7, 8-tetrahydro-1-or-2- naphthalenesul fonyl) agrinine amides or their acid adduct salts
JPS52114091A (en) Preparation of alpha-keto-acid
UA26922C2 (uk) Похідhі сульфамідосульфоhілсечовиhи, що мають гербіцидhу активhість,та гербіцидhа композиція hа їх осhові

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519